Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease (LVH)
Lv Hypertrophy, Heart Failure, Diastolic, Stiffness, Vascular
About this trial
This is an interventional treatment trial for Lv Hypertrophy focused on measuring LVH, Ventricular Stiffness, Fitness, HFpEF
Eligibility Criteria
Inclusion Criteria:
- Presence of left ventricular hypertrophy (by MRI, echocardiography or ECG)
- Normal ejection fraction (>50%)
- Elevated cardiac biomarker (high sensitivity troponin, NT-BNP)
Exclusion Criteria:
- age < 40 or >64
- body mass index>35
- history of heart failure, myocarditis, restrictive cardiomyopathy, severe chronic obstructive pulmonary disease, unstable coronary artery disease or recent (<12 month) acute coronary syndrome, cerebrovascular disease as evidenced by prior transient ischemic attack or stroke and active/recent tobacco use (quit < 5 years).
- chronic orthopedic injury that precludes exercise testing
Sites / Locations
- The Institute for Exercise and Environmental Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
High Intensity Exercise
Yoga
Subjects randomized to receive high intensity aerobic exercise will undergo exercise training for 1 year. A training program will be developed individually for each subject with the goal of increasing duration and intensity consistent with exercise training principles. Workouts will vary with respect to mode (walk, cycle) and duration (30 - 60 minutes). Each subject will be assigned an exercise physiologist and a heart rate monitor so that each session can be tracked and recorded.
Subjects randomized to yoga will receive instructions on strength and flexibility exercises.